Related by context. All words. (Click for frequent words.) 80 mg BID 79 mcg kg 79 mg TID 78 #mg QD [002] 76 mg d 75 #mg BID [001] 75 achieved ACR# 75 mcg BID 75 mg ustekinumab 75 8mg/kg 75 Peg IFN 74 mg qd 74 mg dose 74 lopinavir r arm 74 plus methotrexate 74 LEXIVA r 73 CIMZIA TM 73 administered subcutaneously 73 4mg/kg 73 alfa 2a 73 mg m² 73 #mg/m# [001] 73 budesonide pMDI 73 LPV r 73 lopinavir r 73 ritonavir boosted 73 μg dose 73 mcg doses 73 lispro 72 #mg/m# [002] 72 #mg BID [003] 72 mg RDEA# 72 ribavirin RBV 72 mcg QD 72 abacavir lamivudine 72 ACTEMRA TM 72 tolterodine ER 72 certolizumab 72 #mg/day [001] 72 peginterferon alfa 2b 72 q#h 71 mg kg dose 71 3mg/kg 71 peginterferon alfa 2a 71 chlorambucil 71 active comparator 71 mcg dose 71 mg/m2/day 71 #mg/day [002] 71 mg subcutaneously 71 desvenlafaxine succinate 71 mg/m2 71 rapid virologic response 71 saline placebo 71 APTIVUS r 71 mcg albinterferon alfa 2b 71 q8h 70 aminotransferase elevations greater 70 achieved PASI 70 placebo p = 70 μg kg 70 piperacillin tazobactam 70 atazanavir ritonavir 70 comparator arm 70 subcutaneous enoxaparin 70 oxycodone CR 70 mg tid 70 #mg/kg [002] 70 zonisamide SR 70 mg eq 70 Pegasys ® 70 adalimumab 70 octreotide LAR 70 ug kg 70 oral rivaroxaban 70 weekly subcutaneous injections 70 mcg Albuferon 70 ULORIC 69 intravenous bolus 69 #mg QD [001] 69 mg/m2 administered 69 amoxicillin clavulanate 69 inhalations twice 69 insulin detemir 69 plus dexamethasone 69 peginterferon alfa 2a #KD 69 nicardipine 69 PEG IFN 69 VELCADE melphalan 69 mcg 69 HBeAg seroconversion 69 LANTUS R 69 Pegasys plus Copegus 69 PREZISTA r 69 ALVESCO 69 mg Lucentis 69 dosing cohorts 69 mg/m2 dose 69 nadolol 69 daunorubicin 69 FOLFOX 69 mg/m2 IV 69 tapentadol ER 69 Apidra ® 69 Q2W 69 doxorubicin cyclophosphamide 69 receiving INTRON 69 interferon alfa 2b 69 BARACLUDE ® 69 Engerix B 68 tipranavir r 68 CCyR 68 potent CYP#A# inhibitors 68 flutamide 68 plus prednisone prednisolone 68 plus prednisone 68 PREZISTA ritonavir 68 #.#mg/dL 68 infliximab monotherapy 68 ritonavir boosted atazanavir 68 treatment naïve genotype 68 continuous intravenous infusion 68 mg/# mg [001] 68 log# IU mL 68 interferon alfa 2a 68 Fludara 68 achieved statistical significance 68 HBeAg negative patients 68 PEGINTRON TM 68 #mg doses [002] 68 darunavir ritonavir 68 Acetate Rectal Suppositories 68 PEGASYS ® 68 pegylated interferon alpha 68 dalteparin 68 pegylated interferon alfa 2a 68 plus ribavirin 68 daily subcutaneous injections 68 zolmitriptan 68 biphasic insulin aspart 68 subcutaneously administered 68 clodronate 68 dose cohort 68 unfractionated heparin 68 mg orally 68 tenofovir emtricitabine 68 oral prednisone 68 somatostatin analog 68 Aptivus ® 68 5-FU/LV 68 FOLFOX4 68 mg simvastatin 68 placebo dexamethasone 68 mg doses 68 microgram kg 68 carboplatin paclitaxel 68 COPEGUS 68 fluticasone salmeterol 68 #μg [002] 68 QD dosing 68 adjunctive placebo 68 RLAI 68 evaluable 68 mg administered orally 68 sUA 68 receiving VICTRELIS 67 mCi kg 67 mg/# hr 67 placebo p 67 REYATAZ r arm 67 severe neutropenia 67 biologic DMARD 67 ARCOXIA 67 rFSH 67 plus gemcitabine 67 PEGylated anti 67 peg IFN 67 ibandronate 67 undetectable HCV RNA 67 DOXIL 67 FOLFIRI 67 plus COPEGUS 67 mg kg 67 FOLFOX4 alone 67 biochemical relapse 67 oral vancomycin 67 FOLFOX6 67 CHOP chemotherapy 67 mg p = 67 #.#g/day 67 #.#mg/kg [002] 67 ACR# response 67 COMBIVIR 67 #mg #mg #mg [003] 67 ug dose 67 PegIFN 67 events AEs 67 MCyR 67 tirofiban 67 mcg kg REBETOL 67 relapsed MM 67 doxazosin 67 Pharmacokinetics PK 67 ABC/3TC 67 cytarabine daunorubicin 67 evaluable subjects 67 CANCIDAS 67 mg m 67 undetectable HBV DNA 67 BENICAR 67 oral allopurinol 67 posaconazole 67 REYATAZ r 67 achieved CCyR 67 Mg Uk 67 Flu Cy 67 peginterferon alfa 2a Pegasys 67 5 Fluorouracil 67 QTcF 67 DAPT 67 pegylated interferon alfa 2b 67 RGT arm 67 #mg dose [002] 67 randomized #:#:# 67 adefovir 67 nab paclitaxel 67 urate lowering therapy 67 rizatriptan 66 Mg Usa 66 mitoxantrone plus 66 salmeterol fluticasone 66 certolizumab pegol 66 non splenectomized 66 cisplatin gemcitabine 66 NovoLog ® Mix 66 dexamethasone Decadron 66 mitoxantrone 66 intermittent dosing 66 dosed orally 66 dapagliflozin plus 66 ascending dose 66 brand ciclesonide HFA 66 Lantus ® 66 Hycamtin ® 66 divalproex sodium 66 TO AVOID PREGNANCY WHILE 66 #mg q8h 66 Folfox 66 estramustine 66 hour bronchodilation 66 FUSILEV enhances 66 octreotide 66 SVR# 66 amprenavir 66 oral antidiabetic medication 66 monotherapy 66 TMC# r 66 fluticasone furoate 66 #mg/#mg 66 pegylated interferon alfa 66 mg q8h 66 evaluating tivozanib 66 injected subcutaneously 66 TDF FTC 66 IV bolus 66 PRADAXA #mg 66 humanized interleukin 6 66 FOLPI 66 FOLFIRI alone 66 alpha 2a 66 μmol L 66 quetiapine 66 hypomagnesemia 66 fluticasone 66 virologic failure 66 Tarceva TM 66 docetaxel chemotherapy 66 HBeAg positive patients 66 treatment naive genotype 66 1mg 2mg 66 plus MTX 66 IFN alfa 66 Peginterferon 66 median PFS 66 liposome injection 66 ribavirin therapy 66 placebo 66 progression TTP 66 irbesartan 66 PROCTOCORT ® Suppository Hydrocortisone 66 olanzapine risperidone 66 PROMACTA 66 partial remissions 66 mg/# h 66 inactive placebo 66 receiving prophylactic anticoagulation 66 fluticasone propionate 66 unfractionated heparin UFH 66 tiotropium 66 lanthanum carbonate 66 intravenous dosing 66 bupropion SR 66 #mg dose [001] 66 abacavir sulfate lamivudine 66 ropivacaine 66 dose dexamethasone 66 azilsartan medoxomil 66 dose cohorts 66 TNF Tumor Necrosis Factor 66 ALT normalization 66 postmenopausal osteoporotic women 66 EURIDIS 66 etanercept 66 TORISEL 66 sustained virologic response 66 LEXIVA 66 3TC lamivudine Epivir 66 KAPIDEX 66 μg 66 pyrazinamide 66 patients evaluable 66 tamsulosin 66 budesonide 66 octreotide acetate 66 CR CRu 66 golimumab CNTO 66 5 FU leucovorin 66 dose regimens 66 intravitreal injection 66 plasma HCV RNA 66 IU mL 66 prucalopride 66 BEACOPP 65 mg dosed 65 telaprevir dosed 65 achieved sustained virologic 65 Free Survival PFS 65 tolvaptan 65 docetaxel Taxotere ® 65 plus OBT 65 relapsed refractory multiple myeloma 65 R# #mg BID 65 zoledronate 65 melphalan prednisone 65 ceftazidime 65 solifenacin 65 metformin sulfonylurea 65 mg/# hours 65 subcutaneous injections 65 vinorelbine 65 lumbar spine BMD 65 subcutaneous SC 65 aspirin heparin 65 Psoriasis Area 65 5mg/kg 65 ARIXTRA 65 randomized #:# 65 intramuscularly 65 Doxil ® 65 plus glycoprotein IIb 65 MoxDuo TM IR 65 μg doses 65 PASI scores 65 IIIa inhibitor 65 mycophenolate mofetil 65 binary restenosis 65 ATACAND 65 serum phosphorus 65 lacosamide 65 BUPHENYL 65 APTIVUS 65 Xeloda ® 65 diuretic chlorthalidone 65 methotrexate monotherapy 65 mg q#h 65 candesartan cilexetil 65 adalimumab Humira 65 #.#/#.# mmHg [001] 65 visilizumab 65 oral levofloxacin 65 stage IIIb IV 65 mg subcutaneous 65 mcg linaclotide 65 copies mL 65 DLTs 65 Secondary endpoints included 65 tiotropium bromide 65 BENICAR HCT 65 naïve HCV 65 Zometa hazard 65 fluorouracil 65 mg/#.# mg [003] 65 lopinavir ritonavir 65 oral diclofenac 65 triamcinolone 65 #ug [001] 65 Median PFS 65 log# copies mL 65 mcg mL 65 receiving VELCADE 65 virologic response 65 #mg ritonavir 65 prednisone prednisolone plus 65 doripenem 65 8mg 65 interferon ribavirin 65 CRp 65 KOMBIGLYZE XR 65 P = .# 65 hydroxymethyl coenzyme 65 NPH insulin 65 multicenter Phase III 65 pyrimidine nucleoside analog 65 subcutaneous dose 65 mGluR5 negative 65 levetiracetam 65 headache nasopharyngitis 65 teriflunomide 65 dosing cohort 65 sitagliptin 65 ZYVOX 65 interferon alfa 65 VIRAMUNE 65 ertapenem 65 tenofovir disoproxil fumarate 65 nadroparin 65 glatiramer acetate 65 TAXOTERE R 65 alanine aminotransferase 65 mg/# mg [002] 65 Pegasys peginterferon alfa 2a 65 epoetin alpha 65 Cmax 65 mg dosed twice 65 fumarate 65 timepoints 65 ribavirin USP 65 #μg [001] 65 Dabigatran etexilate 65 nevirapine Viramune 65 dacarbazine 65 plus medroxyprogesterone acetate 64 low dose cytarabine 64 CIMZIA TM certolizumab pegol 64 response CCyR 64 ancrod 64 cisplatin vinorelbine 64 mg 64 RoACTEMRA 64 decitabine 64 degarelix 64 Oral Suspension Oral Suspension 64 ORENCIA ® 64 sirolimus eluting stent 64 HCV RESPOND 2 64 efavirenz EFV 64 BUPHENYL R sodium phenylbutyrate 64 Primary endpoints 64 Lantus R 64 FIRMAGON 64 IFN α 64 TMC# C# 64 log# 64 fosamprenavir 64 SCH # 64 PEGylated interferon beta 1a 64 FEMALES SHOULD BE ADVISED 64 PREZISTA r arm 64 fluorouracil leucovorin 64 PEG Intron 64 intravenous REOLYSIN 64 forodesine 64 NEXIUM 64 esomeprazole 64 discontinuations due 64 glulisine 64 hypokalemia 64 #/#.# mcg 64 #mg dose [003] 64 AUC0 64 sorafenib Nexavar 64 CIMZIA ™ 64 dasatinib Sprycel ® 64 virus HCV protease inhibitor 64 MACUGEN 64 tinidazole 64 vicriviroc 64 EUFLEXXA R 64 Durezol 64 ZOLINZA 64 nitazoxanide 64 TPV r 64 gout flares 64 balsalazide disodium Capsules 64 aspartate aminotransferase 64 CLARITY study 64 ELOXATIN 64 hours postdose 64 ARIKACE 64 XIENCE V PROMUS Stent 64 REBETOL 64 insulin lispro 64 highly emetogenic 64 timolol 64 plus GP IIb 64 HCTZ 64 lopinavir ritonavir Kaletra 64 receiving golimumab 64 VFEND 64 CAELYX 64 Telithromycin 64 mRCC 64 leuprorelin 64 #mg BID [002] 64 dose cytarabine 64 tazobactam 64 spontaneous bowel movements 64 rotigotine 64 nucleoside naive 64 sustained virological response 64 DAS# remission 64 Inhalation Aerosol 64 insulin glulisine 64 Lamictal XR 64 vapreotide acetate 64 Traficet EN 64 REYATAZ R 64 moderate renal impairment 64 bleeding pallor 64 COLAZAL ® 64 ketorolac 64 urinary N telopeptide 64 detemir 64 weekly intravenous infusions 64 NOXAFIL 64 Adverse events 64 daily Infergen 64 metformin HCl 64 mg hydrochlorothiazide 64 stavudine d4T 64 ARB telmisartan 64 chemoradiation therapy 64 lamivudine 64 Raptiva r 64 PEG Interferon alfa 64 fasting plasma glucose FPG 64 pegylated liposomal doxorubicin 64 Darunavir 64 pooled comparator 64 mCi m 2 64 rilonacept 64 apremilast 64 Monotherapy 64 LEVAQUIN ® 64 ascending doses 64 standard chemotherapy regimen 64 p = #.# [004] 64 peg interferon 64 Vfend 64 corticosteroid dose 64 complete cytogenetic response 64 ethambutol 64 AAG geldanamycin analog 64 Crohn Disease Activity 64 icatibant 64 transaminase elevations 64 XELOX 64 Oral Fingolimod 64 Peginterferon Alfa 2a 64 CR nPR 64 SPRYCEL ® 64 darbepoetin alfa 64 PEGylated Fab fragment 64 sorafenib tablets 64 caspofungin 64 peginterferon alpha 2a 64 clopidogrel Plavix 64 otamixaban 64 ara C 64 infliximab 64 cilostazol 64 azathioprine 64 pharmacologically active isomer 64 primary hypercholesterolemia 64 milligram doses 64 placebo intravenously 64 PegIntron 64 topical gel formulation 63 pegylated interferon peg IFN 63 recurrent genital herpes 63 aripiprazole Abilify 63 Taxotere ® 63 anthracycline taxane 63 low dose Iluvien 63 nelfinavir 63 CONCERTA 63 virological failure 63 Prograf ® 63 adefovir dipivoxil 63 NATRECOR R 63 intraocular inflammation 63 splenectomized patients 63 Pivotal Phase III 63 statistically significant p 63 splenectomized 63 kBq kg 63 mucosal healing 63 pegIFN 63 COZAAR 63 valsartan amlodipine 63 -#.# log# copies mL 63 bortezomib refractory 63 pioglitazone HCl 63 Losartan Potassium 63 methylnaltrexone bromide 63 pramipexole 63 myelodysplastic myeloproliferative diseases 63 PRADAXA 63 subcutaneous insulin 63 μg mL 63 glimepiride 63 maximally tolerated dose 63 BARACLUDE R 63 -#.# log# 63 Known hypersensitivity 63 colesevelam HCl 63 clomipramine 63 pamidronate 63 CrCl 63 levofloxacin 63 Median survival 63 bendamustine 63 febrile neutropenia 63 Medoxomil 63 Copegus ribavirin 63 mg BID dose 63 dose colchicine 63 oxycodone IR 63 dosage regimens 63 refractory NSCLC 63 evaluable patients 63 REMICADE monotherapy 63 virologic breakthrough 63 abciximab 63 IXEMPRA 63 NATRECOR ® 63 beta2 agonist 63 tinzaparin 63 titrated glipizide 63 epoetin alfa 63 cGy 63 SYMBICORT 63 rFVIIa 63 undetectable virus HCV 63 efavirenz emtricitabine 63 #mg #mg [001] 63 endoscopic remission 63 tumor progression TTP 63 MIRCERA 63 alfa 2b 63 abatacept 63 Omacetaxine mepesuccinate 63 Newly Diagnosed Multiple Myeloma 63 budesonide formoterol 63 infusional 5-FU/LV 63 receiving PEGINTRON 63 Fluticasone 63 receiving highly emetogenic 63 AZT zidovudine Retrovir 63 salmeterol fluticasone propionate 63 Copegus 63 adriamycin 63 IU ml 63 BoNTA 63 lenalidomide Revlimid R 63 definite stent thrombosis 63 mEq L 63 Cream USP 1 63 thromboembolic events 63 x ULN 63 deep venous thromboses 63 HCV Genotype 63 R adefovir dipivoxil 63 mg OSMOPREP ® 63 erlotinib Tarceva ® 63 pegylated alpha interferon 63 adjunctive ABILIFY 63 #/#mg 63 mIU mL 63 PROCTOCORT R 63 ISENTRESS 63 steroid dexamethasone 63 % Confidence Interval 63 seroprotection 63 febuxostat 63 CorVue ™ 63 administered intranasally 63 hypophosphatemia 63 edoxaban 63 tocilizumab 63 Scale EDSS 63 pruritus itching 63 FluCAM 63 voriconazole 63 cyclophosphamide doxorubicin vincristine 63 CTA# Injection 63 zidovudine lamivudine 63 vandetanib 63 beclomethasone dipropionate 63 FOLFOX6 chemotherapy regimen 63 mesalamine 63 beta 1a 63 benazepril 63 HBeAg positive 63 noninferior 63 Investigational Oral 63 paricalcitol 63 SCIg 63 pharmacokinetics PK 63 antiandrogen 63 antiretroviral naive 63 GOUT 63 serum urate 63 tipranavir 63 eptifibatide 63 Pegylated Liposomal Doxorubicin 63 HbA1c levels 63 eplerenone 63 bosentan 63 mg kg IV 63 Camptosar ® 63 lamivudine refractory patients 63 INVEGA ® 63 Viread Emtriva 63 MAGE A3 ASCI 63 unresectable HCC 63 mesalamine granules 63 cells uL 63 blinded randomized placebo controlled 63 saquinavir ritonavir 63 Sandostatin ® 63 -#.# mg dL [002] 63 n = 63 Aflibercept 63 Paraplatin ® 63 venlafaxine ER 63 idarubicin 63 darunavir r 63 dose titration 63 tacrolimus ointment 63 atazanavir sulfate 63 6mg 63 Capesaris 63 OADs 63 KRAS mutations occur 63 PSA nadir 63 interferon gamma 1b 63 Tipranavir 63 fluconazole 63 adefovir treated 63 odanacatib 63 microbiological eradication 63 dihydrochloride 63 mcg kg min 63 oral prodrug 63 REMICADE ® 63 mometasone furoate 63 protease inhibitor PI 63 dosing intervals 63 TYGACIL 63 Betaferon R 63 % CI #.#-#.# [003] 63 recurrent glioblastoma multiforme 63 transdermal fentanyl 63 galiximab 63 Copegus ® 63 aspartate aminotransferase AST 63 Chronic Hepatitis C 63 plus 5-FU/LV 63 annualized relapse 63 plasma uric acid 63 pegylated interferon 63 noninferiority 63 Pegylated interferon 63 R rilonacept Injection 63 telaprevir dosing 63 CLINICAL STUDIES 63 systemic corticosteroid 63 morphometric vertebral fractures 63 ezetimibe simvastatin 63 Lubiprostone 63 ® tenofovir disoproxil 62 fondaparinux sodium 62 Alkeran 62 risedronate Actonel 62 interferon beta 1a 62 Montgomery Asberg Depression 62 tenofovir FTC 62 atorvastatin #mg 62 gemcitabine carboplatin 62 pomalidomide 62 nasopharyngitis 62 TEAEs 62 aspirin clopidogrel 62 Albuferon TM 62 insulin glargine rDNA origin 62 IMiDs ® compound 62 lamivudine 3TC 62 glycoprotein IIb IIIa inhibitor 62 ropinirole 62 TAXUS Express Stent 62 free survival PFS 62 Adjunctive Therapy 62 MADRS score 62 LMWH 62 AEGR 62 exenatide injection 62 MGd 62 demonstrated clinically meaningful 62 AGILECT R 62 Secondary endpoints include 62 VIRAMUNE XR 62 detectable HCV RNA 62 pimecrolimus cream 62 undetectable viral 62 Severity Index PASI 62 Meets Primary Endpoint 62 orally administered inhibitor 62 BENCHMRK 62 prior chemotherapy regimens 62 statistically significant p = 62 angiotensin converting enzyme inhibitor 62 basal bolus regimen 62 mg kg BID 62 Capecitabine 62 Navelbine 62 NOXAFIL Oral Suspension 62 MIRAPEX 62 bronchodilation 62 Contrave# 62 baminercept 62 Ondansetron Injection USP 62 leukopenia 62 acarbose 62 NEUPOGEN R 62 fatigue asthenia 62 MBq 62 idraparinux 62 REMINYL ® 62 epoetin beta 62 AIR CF1 62 Irinotecan 62 REVLIMID ® 62 analgesic efficacy 62 docetaxel Taxotere R 62 cinacalcet 62 Ranolazine 62 rosuvastatin #mg 62 methotrexate MTX 62 palonosetron 62 novel VDA molecule 62 antiretroviral naïve 62 FOLPI regimen 62 placebo PBO 62 hyperphenylalaninemia HPA due 62 Neulasta R 62 PREZISTA rtv 62 oral methylnaltrexone 62 AGILECT ® 62 HBeAg negative 62 Pred Forte 62 dexamethasone 62 Pivotal Phase 62 ddI 62 Tindamax 62 FROVA 62 double blinded placebo 62 Q#IR 62 Torisel 62 bolus injection 62 Ziprasidone 62 MAS XR 62 APIDRA R 62 salmeterol inhalation powder 62 PegIFN RBV 62 GAMMAGARD 62 paliperidone palmitate 62 goserelin 62 bolus dose 62 Taxotere R 62 #mg ATC 62 ONGLYZA 62 Posaconazole 62 R tenofovir disoproxil 62 Peginterferon alfa 2a 62 achieved mucosal healing 62 fluvastatin 62 investigational protease inhibitor 62 genotypic resistance 62 valacyclovir 62 budesonide foam 62 Single Dose 62 oxcarbazepine 62 alanine aminotransferase ALT 62 ng dL 62 achieved sustained virological 62 docetaxel 62 relapsing multiple sclerosis 62 BRIM2 62 CIMZIA R 62 subcutaneous doses 62 seropositive patients 62 metastatic GIST 62 Randomized Double Blind 62 p = #.# [002] 62 Captisol Enabled 62 Pemetrexed 62 inhaled corticosteroid ICS 62 placebo controlled clinical trials 62 Teriflunomide 62 risperidone Risperdal 62 Ceplene/IL-2 62 bone marrow reticulin deposition 62 pegylated interferon alpha 2a 62 cell lymphoma CTCL 62 placebo controlled Phase 62 non valvular atrial 62 GnRH agonist 62 Peginterferon alfa 2b 62 cytogenetic response 62 EPIVIR 62 acute gout flares 62 CYT# potent vascular disrupting 62 benzoic acid hyoscyamine sulfate 62 statin monotherapy 62 sunitinib Sutent ® 62 SGPT 62 complete cytogenetic 62 medroxyprogesterone acetate 62 tipranavir ritonavir 62 MoxDuo IR 62 ciclesonide 62 HCV SPRINT 62 cyclophosphamide methotrexate 62 ketoconazole 62 boosted protease inhibitor 62 virologically suppressed 62 Index CDAI 62 dyskinesia PD LID 62 crizotinib PF # 62 STELARA 62 1mg 62 IMiDs ® 62 TYKERB 62 MULTAQ 62 Coadministration 62 stage IIIB 62 TNF antagonists 62 epirubicin cisplatin 62 p = NS 62 mg Proellex 62 patients undergoing percutaneous 62 recurrent GBM 62 Sanofi Pasteur Fluzone 62 #:# randomization 62 emtricitabine tenofovir 62 metastatic malignant 62 ACTEMRA 62 temsirolimus 62 enfuvirtide 62 PRN FDA Approves 62 Epothilone D 62 administered orally 62 sevelamer carbonate 62 alpha blocker 62 lenalidomide Revlimid ® 62 fosbretabulin 62 alpha 2b 62 Eloxatin R 62 cEVR 62 acyclovir Lauriad R 62 virological response 62 CsA 62 Phase 2b study 62 trastuzumab Herceptin R 62 triptorelin 62 enalapril 62 tapentadol IR 62 leukotriene receptor antagonist 62 arsenic trioxide injection 62 creatinine clearance 62 coadministration 62 equi analgesic doses 62 subcutaneously injected 62 sumatriptan naproxen sodium 62 tenofovir Viread 62 microg 62 WBRT alone 62 Jevtana